UB Paderborn / Katalog / Suche / in CDI

Non‐disclosure of HIV serostatus to sexual partners: Prevalence, risk factors and clinical impact in patients with HIV

HIV medicine, 2021-03, Vol.22 (3), p.194-200

2021

Volltextzugriff (PDF)

Peru-15 (Choleragarde® ), a live attenuated oral cholera vaccine, is safe and immunogenic in human immunodeficiency virus (HIV)-seropositive adults in Thailand

Vaccine, 2015-09, Vol.33 (38), p.4820-4826

2015

Volltextzugriff (PDF)

Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients

International journal of STD & AIDS, 2011-11, Vol.22 (11), p.665

2011

Volltextzugriff (PDF)

Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks

Journal of antimicrobial chemotherapy, 2013-03, Vol.68 (3), p.697-707

2013

Volltextzugriff (PDF)

Nevirapine‐associated hepatotoxicity was not predicted by CD4 count ≥250 cells/μL among women in Zambia, Thailand and Kenya

HIV medicine, 2010-11, Vol.11 (10), p.650-660

2010

Volltextzugriff (PDF)

Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study

Journal of acquired immune deficiency syndromes (1999), 2007-10, Vol.46 (2), p.125

2007

Volltextzugriff (PDF)

Sustained antiretroviral effect of raltegravir after 96 weeks of combination therapy in treatment-naive patients with HIV-1 infection

Journal of acquired immune deficiency syndromes (1999), 2009-11, Vol.52 (3), p.350

2009

Volltextzugriff (PDF)

Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV

Scientific reports, 2023-03, Vol.13 (1), p.4749-4749, Article 4749

2023

Volltextzugriff (PDF)

Bacteremia Due to Motile Enterococcus Species: Clinical Features and Outcomes

Clinical infectious diseases, 1999-05, Vol.28 (5), p.1175-1177

1999

Volltextzugriff (PDF)

Evaluation of antiretroviral drug efficacy for HIV-1 encephalitis in SCID mice

Neurology, 2000-01, Vol.54 (2), p.379

2000

Volltextzugriff (PDF)

A Decade of Combination Antiretroviral Treatment in Asia: The TREAT Asia HIV Observational Database Cohort

AIDS research and human retroviruses, 2016-08, Vol.32 (8), p.772

2016

Volltextzugriff (PDF)

Trends of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV‐positive patients

Journal of the International AIDS Society, 2014-01, Vol.17 (1), p.18804-n/a

2014

Volltextzugriff (PDF)

HIV-1 Drug Resistance Mutations Among Antiretroviral-Naive HIV-1—Infected Patients in Asia: Results From the TREAT Asia Studies to Evaluate Resistance-Monitoring Study

Clinical infectious diseases, 2011-04, Vol.52 (8), p.1053-1057

2011

Volltextzugriff (PDF)

Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV

Journal of the International AIDS Society, 2019-03, Vol.22 (3), p.e25264-n/a

2019

Volltextzugriff (PDF)

The occurrence of Simpson's paradox if site-level effect was ignored in the TREAT Asia HIV Observational Database

Journal of clinical epidemiology, 2016-08, Vol.76, p.183-192

2016

Volltextzugriff (PDF)

Sustained efficacy and safety of raltegravir after 5 years of combination antiretroviral therapy as initial treatment of HIV-1 infection: final results of a randomized, controlled, phase II study (Protocol 004)

Journal of acquired immune deficiency syndromes (1999), 2012-09, Vol.61 (1), p.73

2012

Volltextzugriff (PDF)

The Efficacy of Potent Anti-retroviral Drug Combinations Tested in a Murine Model of HIV-1 Encephalitis

Virology (New York, N.Y.), 2001-03, Vol.281 (1), p.21-34

2001

Volltextzugriff (PDF)

Factors associated with suboptimal adherence to antiretroviral therapy in Asia

Journal of the International AIDS Society, 2014-01, Vol.17 (1), p.18911-n/a

2014

Volltextzugriff (PDF)

Comparison of genotypic and virtual phenotypic drug resistance interpretations with laboratory-based phenotypes among CRF01_AE and subtype B HIV-infected individuals

Journal of medical virology, 2016-02, Vol.88 (2), p.234-243

2016

Volltextzugriff (PDF)

Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks

Journal of antimicrobial chemotherapy, 2013-07, Vol.68 (7), p.1695-1695

2013

Volltextzugriff (PDF)

Evaluation of the MycoDot test for the diagnosis of tuberculosis in HIV seropositive and seronegative patients

The international journal of tuberculosis and lung disease, 1997-06, Vol.1 (3), p.259

1997

Volltextzugriff (PDF)

HIV multi‐drug resistance at first‐line antiretroviral failure and subsequent virological response in Asia

Journal of the International AIDS Society, 2014-01, Vol.17 (1), p.19053-n/a

2014

Volltextzugriff (PDF)

Implementation and Operational Research: Effects of CD4 Monitoring Frequency on Clinical End Points in Clinically Stable HIV-Infected Patients With Viral Suppression

Journal of acquired immune deficiency syndromes (1999), 2015-07, Vol.69 (3), p.e85

2015

Volltextzugriff (PDF)

Evaluating immunologic response and clinical deterioration in treatment-naive patients initiating first-line therapies infected with HIV-1 CRF01_AE and subtype B

Journal of acquired immune deficiency syndromes (1999), 2013-03, Vol.62 (3), p.293

2013

Volltextzugriff (PDF)

Relationship between hyperglycemia and the risk of tuberculosis in Asian HIV-positive individuals in the antiretroviral therapy era: cohort study

Journal of acquired immune deficiency syndromes (1999), 2014-08, Vol.66 (5), p.e108

2014

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Non‐disclosure of HIV serostatus to sexual partners: Prevalence, risk factors and clinical impact in patients with HIV

Peru-15 (Choleragarde® ), a live attenuated oral cholera vaccine, is safe and immunogenic in human immunodeficiency virus (HIV)-seropositive adults in Thailand

Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients

Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks

Nevirapine‐associated hepatotoxicity was not predicted by CD4 count ≥250 cells/μL among women in Zambia, Thailand and Kenya

Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study

Sustained antiretroviral effect of raltegravir after 96 weeks of combination therapy in treatment-naive patients with HIV-1 infection

Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV

Bacteremia Due to Motile Enterococcus Species: Clinical Features and Outcomes

Evaluation of antiretroviral drug efficacy for HIV-1 encephalitis in SCID mice

A Decade of Combination Antiretroviral Treatment in Asia: The TREAT Asia HIV Observational Database Cohort

Trends of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV‐positive patients

HIV-1 Drug Resistance Mutations Among Antiretroviral-Naive HIV-1—Infected Patients in Asia: Results From the TREAT Asia Studies to Evaluate Resistance-Monitoring Study

Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV

The occurrence of Simpson's paradox if site-level effect was ignored in the TREAT Asia HIV Observational Database

Sustained efficacy and safety of raltegravir after 5 years of combination antiretroviral therapy as initial treatment of HIV-1 infection: final results of a randomized, controlled, phase II study (Protocol 004)

The Efficacy of Potent Anti-retroviral Drug Combinations Tested in a Murine Model of HIV-1 Encephalitis

Factors associated with suboptimal adherence to antiretroviral therapy in Asia

Comparison of genotypic and virtual phenotypic drug resistance interpretations with laboratory-based phenotypes among CRF01_AE and subtype B HIV-infected individuals

Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks

Evaluation of the MycoDot test for the diagnosis of tuberculosis in HIV seropositive and seronegative patients

HIV multi‐drug resistance at first‐line antiretroviral failure and subsequent virological response in Asia

Implementation and Operational Research: Effects of CD4 Monitoring Frequency on Clinical End Points in Clinically Stable HIV-Infected Patients With Viral Suppression

Evaluating immunologic response and clinical deterioration in treatment-naive patients initiating first-line therapies infected with HIV-1 CRF01_AE and subtype B

Relationship between hyperglycemia and the risk of tuberculosis in Asian HIV-positive individuals in the antiretroviral therapy era: cohort study

Suchergebnisse filtern